Skip to main content

Faculty Viewpoints

  • How CEOs Should Navigate the Trump Presidency

    Yale SOM leadership expert Jeffrey Sonnenfeld writes that business leaders should engage with the new administration—and remain unified on issues of shared concern.

    Voters in Foster City, California, watch election-night coverage. 
  • For the Youngest, Pertussis Is Dangerous and Preventable

    Pertussis, also known as whooping cough, is on the rise after a pandemic-era lull. Yale SOM’s Dr. Howard Forman says that the disease can lead to hospitalization and even death for the youngest children, but can be prevented by proper vaccination of babies and their mothers.

    Howard Forman
  • Don’t Trust the Political Prediction Markets

    Yale SOM’s Jeffrey Sonnenfeld, co-author Steven Tian, and investor and former White House staffer Anthony Scaramucci write that the markets have extremely low trading volume—which makes it easy to manipulate them.

    A split screen of Kamala Harris and Donald Trump debating, with buttons to buy "yes" or "no" contracts for each of them
  • Who Has the Secret to Manufacturing Success?

    Both Kamala Harris and Donald Trump propose to use government clout to strengthen the U.S. manufacturing industry—though they have very different proposals for how to accomplish this goal. According to an analysis by Yale’s Jeffrey Sonnenfeld and co-authors Laura Tyson and Steven Tian, the record of the last two presidential terms shows the Harris approach to be more effective at actually delivering jobs and economic growth.

    Forklift operator
  • Hamas Leader Yahya Sinwar’s Death Can Bring the Middle East Closer to Peace

    Yale SOM’s Jeffrey Sonnenfeld, co-author Steven Tian, and diplomat Dennis Ross write that Sinwar’s death could ultimately lead to the end of Hamas rule and the political and economic stabilization of Gaza.

    Yahya Sinwar in Gaza City in April 2023.
  • What Critics of Pfizer Are Getting Wrong

    The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management under CEO Albert Bourla. Yale SOM’s Jeffrey Sonnenfeld and co-author Steven Tian write that the critics are demonstrating the same impatience that has led investors to underestimate Pfizer in the past.

    The Pfizer logo and stock price on a display at the New York Stock Exchange
  • How to Lay People Off with Humanity

    Layoffs may sometimes be necessary, writes Yale SOM’s Emma Seppälä, but they are painful, both for departing employees and those remaining in what can be a demoralized and overworked organization. She offers research-based guidance for making the process more compassionate and less disruptive.

    An illustration of scissors cutting strings holding up office workers with computers
  • Celebrating a Milestone in the Campaign to Eliminate a Major Cause of Blindness

    More than two million people have lost their vision, in whole or in part, to trachoma—a preventable infection that is widespread in areas with poor sanitation. Dr. Howard Forman writes that the campaign to eradicate trachoma by 2030 has achieved an important victory: eliminating the disease as a public health problem in India.

    Howard Forman
  • Finding the Blueprint for Thriving Organizations

    Professor James Baron’s research helped establish the now-commonplace understanding that the way a company organizes itself—what we now call its human-capital strategy—is key to creating a happy, equitable culture and ultimately to survival and success.

    James Baron
  • Big Companies Are Not the Inflation Villain

    Blaming corporate greed for rising prices is not a winning argument, write Yale SOM’s Jeffrey Sonnenfeld, economist and former presidential advisor Laura Tyson, and co-author Stephen Henriques.

    A shopper in a supermarket